logo-loader
HealthPharma & Biotech
Netscientific PLC

NetScientific says latest data shows “invaluable potential” of portfolio company Wanda’s technology

Wanda’s patient monitoring technology led to the number of congestive heart failure patients being readmitted to hospital almost halving

doctor in hospital
NetScientific holds a 62% stake in Wanda

Netscientific PLC (LON:NSCI) boss Francois Martelet has heaped praise on portfolio company Wanda after new data confirmed the benefits of its technology.

Wanda has developed a system which continuously assesses patients in real time and can detect adverse events up to a week before they happen.

READ: NSCI looking for hard exits as portfolio matures

By using that technology, the number of hospital readmissions for congestive heart failure patients – a patient population with a typically high readmission rate – almost halved (46% reduction).

There are currently 576 patients enrolled on the programme, but Martelet, who is also chairman of Wanda, thinks the latest figures provide a “strong rationale” for rolling out the system to more people.

“The data are impressive as patients with congestive heart failure typically have a very high re-admission rate,” said Martelet.

“This demonstrates the invaluable potential Wanda's technology has in streamlining care and improving patient outcomes.”

He added: “We are entering a new digital era of healthcare in which we firmly believe Wanda can play a pivotal role, and we are very pleased to see the collaboration with HRS working so well.”

NetScientific holds a 62% stake in Wanda.

Shares rose 12.6% to 49p at the opening bell on Monday.

--Updates for share price--

Quick facts: Netscientific PLC

Price: £0.07

Market: AIM
Market Cap: £5.3 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Netscientific PLC named herein, including the promotion by the Company of Netscientific PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Netscientific PLC raises £5mln to speed up portfolio commercialisation

Francois Martelet, chief executive of Netscientific PLC (LON:NSCI), caught up with Proactive's Andrew Scott following the close of their £5mln fundraise. Netscientific has a core portfolio of five companies and will use the additional funding to accelerate either the float or sale of one...

on 12/4/18

2 min read